J Stroke.  2021 May;23(2):273-276. 10.5853/jos.2020.04588.

Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds

Affiliations
  • 1Department of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
  • 2Department of Neurology, Chonnam National University Hwasun Hospital, Hwasun, Korea
  • 3Molecular Imaging Center, Department of Nuclear Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
  • 4Molecular Imaging Center, Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea


Figure

  • Figure 1. Incidence rates of stroke (A) and secondary outcomes (B-D) among patients receiving antithrombotic therapy. HR, hazards ratio; OAC, oral anticoagulant; AP, antiplatelet; CI, confidence interval.

  • Figure 2. The effects of anticoagulation versus that of antiplatelet therapy on stroke risk according to the burden (A, B) and location (C, D) of cerebral microbleed (CMB). AP, antiplatelet; HR, hazards ratio; OAC, oral anticoagulant; CI, confidence interval.


Reference

References

1. Wilson D, Ambler G, Shakeshaft C, Brown MM, Charidimou A, Al-Shahi Salman R, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018; 17:539–547.
2. Choi KH, Kim JH, Lee C, Kim JM, Kang KW, Kim JT, et al. Microbleeds and outcome in patients with acute ischemic stroke and atrial fibrillation taking anticoagulants. Stroke. 2020; 51:3514–3522.
Article
3. Selim M, Diener HC. Atrial fibrillation and microbleeds. Stroke. 2017; 48:2660–2664.
Article
4. Xian Y, O’Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC, et al. Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation. JAMA. 2017; 317:1057–1067.
Article
5. Shoamanesh A, Charidimou A, Sharma M, Hart RG. Should patients with ischemic stroke or transient ischemic attack with atrial fibrillation and microbleeds be anticoagulated? Stroke. 2017; 48:3408–3412.
Article
6. Wilson D, Charidimou A, Ambler G, Fox ZV, Gregoire S, Rayson P, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis. Neurology. 2016; 87:1501–1510.
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr